Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL
Completed · Phase 2
Conditions studied: Diffuse Large B-cell Lymphoma
In brief
This is a Phase II, Single-Arm, Open-Label, Multicentre Study to Evaluate the Safety and Efficacy of Lenalidomide Combined with MOR00208 in Participants with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL).
Key facts
- Study ID
- NCT02399085
- Run by
- MorphoSys AG
- People needed
- 81
- Starts
- 2016-03-29
- Expected to finish
- 2023-04-19
- Last updated by the study team
- 2023-10-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA - David Geffen School of Medicine — Los Angeles, California, United States
- Cancer Care - Torrance Memorial Physician Network — Redondo Beach, California, United States
- Central Coast Medical Oncology Corporation — Santa Maria, California, United States
- St. Mary's Hospital And Regional Medical Center — Grand Junction, Colorado, United States
- Norwalk Hospital — Norwalk, Connecticut, United States
- St. Joseph Mercy Hospital Cancer Care Center — Ypsilanti, Michigan, United States
- Ohio State University Medical Center — Columbus, Ohio, United States
- Charleston Hematology Oncology Associates — Charleston, South Carolina, United States
- Tyler Hematology-Oncology — Tyler, Texas, United States
- ZNA Middelheim dep Klinische studies Hematologie — Antwerp, Belgium
- AZ Groeninge-Campus Maria's Voorzienigheid — Kortrijk, Belgium
- Centre Hospitalier Universitaire (CHU) de Liege — Liège, Belgium
- Clinique Universitaire de Mont Godinne — Yvoir, Belgium
- University Hospital Olomouc Hematoonkologicka klinika — Olomouc, Czechia
- CHU De Clermont Ferrand - Hopital Estaing Service Hematologie Clinique Et Thrapie Cellulaire — Clermont-Ferrand, France
- Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren — Limoges, France
- Centre Hospitalier Lyon-Sud (CHLS) — Lyon, France
- Hopital Universitaire Necker Enfants Malades Service de Hematologie Adultes — Paris, France
- Universitatsklinikum Essen, Abteilung Haematologie — Essen, Germany
- Krankenhaus Nordwest GmbH - Institut Fuer Klinisch-Onkologische Forschung (IKF) — Frankfurt, Germany
- Klinikum Grosshadern-Klinikum Der Ludwig-Maximilian Universitaet Muenchen — Munich, Germany
- Klinikum Nuernberg Nord Medizinische Klinik 5 Hamatologie — Nuremberg, Germany
- Universitaetsklinikum Wuerzburg — Würzburg, Germany
- Semmelweis Egyetem I. Sz. Belgyogyaszati Klinika-Semmelweis University — Budapest, Hungary
- CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center — Bakersfield, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.